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Abstract: Cardiac autonomic dysfunction has been reported in patients with cerebral palsy (CP).
The aim of this study was to assess the existing literature on heart rate variability (HRV) in pediatric
patients with CP and a special attention was paid to the compliance of the studies with the current
HRV assessment and interpretation guidelines. A systematic review was performed in PubMed,
Web of Science, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases
searched for English language publications from 1996 to 2019 using Medical Subject Headings (MeSH)
terms “heart rate variability” and “cerebral palsy” in conjunction with additional inclusion criteria:
studies limited to humans in the age range of 0–18 years and empirical investigations. Out of 47
studies, 12 were included in the review. Pediatric patients with CP presented a significantly higher
resting heart rate and reduced HRV, different autonomic responses to movement stimuli compared to
children with normal development, but also reduced HRV parameters in the children dependent
on adult assistance for mobility compared to those generally independent. None of the included
studies contained the necessary details concerning RR intervals acquisition and HRV measurements
as recommended by the guidelines. Authors of HRV studies should follow the methodological
guidelines and recommendations on HRV measurement, because such an approach may allow a
direct comparison of their results.
Keywords: cerebral palsy; heart rate variability; cardiac autonomic dysfunction
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1. Introduction
Cerebral palsy (CP) is a neurodevelopmental condition starting in early childhood and lasting
for the whole life. In patients with CP, motor disorders attributed to non-progressive anomalies in
the developing fetal or infant brain are often accompanied by a range of additional disturbances, e.g.,
epilepsy, sensory, perceptive, cognitive, communicational, and behavioral problems [1]. Recently,
numerous studies have been performed to identify alterations in the autonomic nervous system (ANS)
activity, which suggest that children and adolescents with CP present sympathovagal imbalance
compared to peers with normal development [2–14]. Several possible causes are postulated to explain
the cardiac ANS abnormalities in these patients. Firstly, the brain injury affects parts of the ANS and
hence impairs cardiovascular functioning, e.g., heart rate (HR) regulation [15–18], which in turn may
lead to cardiovascular complications [19–22]. Secondly, mobility limitations, lack of physical activity,
and, in general, a sedentary lifestyle observed in this population undermine the ANS and potentiate
the risk of cardiometabolic diseases [23,24]. Finally, the overall regulation of the cardiovascular system
is disturbed, which results in elevated blood pressure and HR.
Heart rate variability (HRV) analysis is a noninvasive measure of the cardiac ANS modulation,
which is widely used to reflect heart-brain interactions [25,26]. Since 1996, when the Task Force of the
European Society of Cardiology and the North American Society of Pacing and Electrophysiology
published standards of measurement, physiological interpretation, and clinical use of HRV [25], a
large number of research and methodological papers in the area of HRV have been published [27–46].
In general terms, reduced HRV indicates ANS imbalance and a poor prognosis in patients with a variety
of clinical conditions [47–50]. Indeed, reduced HRV is often seen in diabetic children with autonomic
neuropathy [51,52], and in those with a clustering of metabolic risk factors [53]. In 2014, a review
assessing the function of the autonomic HR regulation among children with CP was published [10].
Results of the studies included to the review (articles published before 2013) performed by Amichai
and Katz-Leurer [10], but also findings of the articles that were not analyzed by these authors or were
published later, showed that children with CP, in comparison to normally developing peers, present a
decreased overall HRV profile, an increased average HR, and altered autonomic responses to selected
movement maneuvers or physical exercise [4,6,8–12,14,54–56]. However, results of the mentioned
HRV analyses in children with CP are not fully concordant, which may be partially caused by different
methodologies and a lack of compliance with the recommendations of the Task Force [25]. Another
important point to be considered is that there are several limitations regarding the overall assessment
and analysis of HRV that can lead to heterogenous results [34]. Thus, the assessment of whether the
studies of HRV in children with CP followed the recommendations for obtaining RR intervals and
performing HRV analysis is critical for summarizing the current knowledge and for planning future
research. Characterization of the cardiac autonomic control in children with CP is paramount for better
understanding of neurological disturbances and their development in this condition. Furthermore,
by summarizing the effects of interventional studies on HRV, it will be possible to define the role of
HRV analysis in monitoring the autonomic activity in subjects with CP undergoing various modes
of rehabilitation and treatment. In addition, to the best of our knowledge, no review has addressed
compliance of the previously published studies with the proposed methodological recommendations
for the analysis and interpretation of HRV in this population.
Therefore, the aim of this study was to review the existing literature on HRV in pediatric patients
with CP with a particular attention to verifying compliance of the included studies with the current
guidelines for HRV analysis.
2. Literature Search
A systematic search of the literature according to the evidenced-based and consensus-based
Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement [57,58]
was carried out. Three digital databases (PubMed, Web of Science and Cumulative Index to Nursing
and Allied Health Literature (CINAHL) were searched for the studies reporting measurements of
J. Clin. Med. 2020, 9, 1141 3 of 25
HRV in patients with CP. The databases were explored using mesh terms “heart rate variability” and
“cerebral palsy” in conjunction with the following limitations: (i) studies limited to humans; (ii) studies
limited to participants in the age range of 0–18 years; (iii) English language of the publication; (iv)
publication date from March 01, 1996 (date of publication of the standards for HRV analyses [25]), to
July 31, 2019; (v) empirical investigations, i.e., studies involving active data collection. Meta-analyses,
expert opinions, reviews, and single case reports were excluded.
The StArt (State of the Art through Systematic Review) software (developed by the Federal
University of São Carlos) was used to perform the systematic review.
The selected studies were independently analyzed by two researchers (J.S.G. and A.R.Z.), to
minimize the bias. The disagreements between them were resolved through discussion with other
co-authors. Titles and abstracts of all the initially identified articles were screened based on the defined
inclusion criteria—in doubtful cases, full texts of the articles were analyzed. To broaden the research,
references of the eligible articles were also searched for further relevant studies not identified in the
database. Additionally, when it was impossible to download the full text of a relevant study, an e-mail
with the request for the article was sent to the corresponding author.
According to the PICOS approach (each letter of the acronym PICOS refers to: the patient
population or the disease being addressed (P), the interventions or exposure (I), the comparator group
(C), the outcome or endpoint (O), and the study design chosen (S)) [57], the following information was
extracted from each study: (1) first author and year of publication; (2) characteristics of participants
(experimental group—patients with CP; control group—children with normal development); (3) all
conditions concerning RR intervals acquisition; (4) method of HRV analysis; (5) results of HRV analysis,
and (6) main results and conclusions.
The following quality aspects of HRV studies in pediatric patients with CP referring to the
guidelines for HRV analysis were analyzed and reviewed:
• Study sample (the number of patients in the experimental group and of participants in the control
group).
• Data acquisition and processing, where the following points are analyzed:
− Device, software, duration of recordings, and sampling frequency;
− Recording conditions: time of the day, room (lights/voices/temperature), activities before
recordings (sleep routine, physical activities, meals, drinks, using the toilet), and heart
rate stabilization;
− Respiratory rate during recordings and breathing control;
• HRV analysis, where the following points are analyzed:
− Software, artifact correction, time series length (time/beats), information about
data normality;
− Frequency domain and nonlinear HRV parameters;
• HRV correction for HR.
Detailed analysis and explanation of the relevance of each aspect is presented in the Discussion.
3. Results
Data for points (1), (2), (3), and (4) are summarized in Tables 1 and 2, respectively. Detailed
results of the HRV analysis (5) reported in the included studies are presented in Table S1 (time-domain
parameters; Supplementary Materials) and Table S2 (frequency-domain parameters; Supplementary
Materials). Main results and conclusions (6) of the analyzed studies are presented in Table 3. The search
procedure, i.e., the number of studies meeting the pre-defined inclusion criteria and the number of
excluded and accepted studies is illustrated in Figure 1.
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Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow 
diagram for the search process.
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow
diagram for the search process.
3.1. Selection of the Studies
The search of the databases yielded a total number of 47 articles (Figure 1). After removing
duplicates, 31 articles remained—of these, 4 studies were discarded because they did not meet the
established criteria. From the 27 remaining studies, after full text analysis and data extraction, 15
articles were excluded with specified reasons (see the flow diagram in Figure 1). A total of 12 studies
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were therefore included in the systematic review. No additional study was identified by checking the
references within these 12 studies.
3.2. Information Provided by the Selected Studies
3.2.1. Participants/Demographic Data
The included studies involved 397 participants with CP and were conducted in the period from
2002 to 2019. Details concerning age, sex, Gross Motor Function Classification System (GMFCS) level,
and type of paralysis for patients with CP are presented in Table 1. Data describing the control group
were available in 8 studies. In one study, patients with CP were considered the control group for
children with acute brain injury (Table 1).
3.2.2. RR Interval Recordings
Details concerning RR intervals acquisition are given in Table 1. Long-time recordings, i.e., 24-h
ECGs, were performed in 1 study. Short-time RR interval recordings were used in 7 studies and the
duration of recordings ranged from 3 to 15 min—in 4 studies, the length of RR interval recordings was
not provided or there was lack of precise description. In 5 studies, the Polar Advanced Heart Rate
Monitor was used. Sampling frequency varied within the range from 250 to 1000 Hz. The authors
of 8 studies provided information about the software that was used to acquire the RR intervals.
Comprehensive information about both sampling frequency and recording duration was provided in 3
studies. None of the studies employing short-term recordings provided comprehensive information
and description on the time of data acquisition, conditions in the room where the study took place,
the period preceding the recordings (i.e., the time needed for HR stabilization), and conditions before
recordings (i.e., sleep routine, physical training, meals, drinks, using the toilet). In 3 studies, the
breathing rate was controlled. In 7 studies, short-term recordings were performed in the supine
position—in 6 of these studies, data were also recorded in other positions.
3.2.3. HRV Measurement
Table 2 shows information about HRV measurements. One study provided details on the software
used for calculation of HRV parameters, artifact correction and the length of the time series used for
the HRV analysis. HRV parameters were calculated based on the time series length equal to 5 min
(short-term recordings) or 18 h (long-term recordings). Two studies presented results of the time-
and frequency-domain analyses and the nonlinear dynamics analysis. Three studies showed data
concerning only frequency-domain parameters and 2 studies presented results of only time-domain
parameters. In 3 articles, the authors specified how data distribution was checked.
3.2.4. HRV Results
Detailed raw results reported in the included studies concerning HR, time-domain,
frequency-domain, and nonlinear HRV parameters are presented in Tables S1 and S2, respectively. In
Table 3, the main results and conclusions taken from these studies are presented.
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RR Intervals Acquisition
Software for RR Intervals
Acquisition, Sampling
Frequency, and Duration of
Recordings
Time of the Day and
Room
(Lights/Voices/Temperature)
Activities (Sleep Routine, Physical
Activities, Meals, Drinks, Using the Toilet
before Recordings) and Instructions Given.





















carried out at about 3:00
pm in a quiet room at
room temperature 20–24
◦C.
Subjects had a very light lunch.
10 min
Subjects were instructed
to breathe with a
metronome at 15
breaths/min (0.25 Hz).
Supine, 70◦ head-up tilt
using a tilt table
Yang et al.,
2002 [3]








by one of the authors
Sampling: 256 Hz
Duration: 288 s





90 children with CP (58♂).
Age: 3–15 years; 31:
quadriplegia, 31: diplegia,
6: hemiplegia









24 h monitoring Not reportedNot reported Not reported Not applicable
Zamunér et al.,
2011 [5]
12 children with CP (7♂).
Age: 4–13 years; 4:
quadriplegia, 6: diplegia,
2: hemiplegia









The children and their parents were given
instructions to avoid consumption of
stimulating beverages, to suspend any major
physical activity, to have light meals, and to
have a good night’s rest. All children were
familiarized with the experimental
proceedings during a pilot test conducted a
week prior to the study procedures.










26 children with CP (12♂).
Age: 8–14 years;
13: quadriplegia, 9:




children (6♂) matched for
age






Duration: lack of precise





performed in a quiet room,
with the temperature
between 21–26◦C.
Before data collection, each subject was
familiarized with the study protocol. Every
attempt was made to control external factors:
similar assessment time, restriction of activity,
and/or heavy meal prior to the Holter
recording.
Lack of precise description
Not reported Supine, during walking
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RR Intervals Acquisition
Software for RR Intervals
Acquisition, Sampling
Frequency, and Duration of
Recordings
Time of the Day and
Room
(Lights/Voices/Temperature)
Activities (Sleep Routine, Physical
Activities, Meals, Drinks, Using the Toilet
before Recordings) and Instructions Given.








et al., 2014 [9]
30 children with CP (17♂).










min, highest activity achieved
in the GMFM assessment
performed over and over
again for 2 min, standing—10
min
All procedures were
performed in a quiet room,
with the temperature
between 21–26 ◦C.
Before data collection, each subject was
familiarized with the study protocol.







20 children with CP (12♂).








Duration: lack of precise
description. No information
whether 5 min were
dedicated for a rest or RR
interval recording.
Not reported
The children were asked to sit quietly at rest
for 5 min and then to walk on the treadmill.
Not reported
Not reported Sitting, walking
Cohen-Holzer et
al., 2017 [13]
24 children with unilateral








Not reported Not reportedNot reported Not reported Not reported





Experimental Group Control Group
RR Intervals Acquisition
Software for RR Intervals
Acquisition, Sampling
Frequency, and Duration of
Recordings
Time of the Day and
Room
(Lights/Voices/Temperature)
Activities (Sleep Routine, Physical
Activities, Meals, Drinks, Using the Toilet
before Recordings) and Instructions Given.







Kim et al., 2017
[56]
13 children with CP (8♂)
considered as control





group for the children






between 1:00 and 3:00 PM.
The room temperature
during data collection was
24–26 ◦C.
Not reported
30 min Not reported Supine
Amichai et al.,
2019 [12]
20 children with CP (15♂).












Duration: HRV data were
recorded throughout the
entire session.
Not reported Not reportedNot reported
The children were asked
to lie down quietly on the
back for 5 min, then to sit
quietly in a resting state
for 5 min, followed by a
paced breathing training
(15 min). Paced breathing
and breathing rate were
evaluated using the
ProRelax software (ver.






110 children with CP
(66♂). Age: 6–11 years;
GMFCS I-V
35 typically developed
children matched for age
Software: Polar Advanced
Heart Rate Monitor RC800CX
Sampling: not reported
Duration: 10 min
Testing was performed in
the morning hours, in a
quiet room with the
temperature between
21–26 ◦C.
The children were asked not to consume a
heavy meal, drink caffeinated beverages, or
perform physical activities for at least 2 h
before testing.
Not reported
Not reported Not reported
Landis et al., 2019
[54]
10 children with CP (4♂).
Mean age: 15.5 ± 3.6
years; 4: diplegia, 6:
hemiplegia. GMFCS II-III
No control group
Software: Heart rate monitor
(name of the software not
reported)
Sampling: 250 Hz
Duration: 5 min; conditioning
phase (10 min) divided into
two 5 min phases
Not reported Not reported5 min Not reported Sitting
CP—cerebral palsy; GMFCS—Gross Motor Function Classification System; GMFM—Gross Motor Function Measure; HRV—heart rate variability; ECG—electrocardiography.
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Table 2. Heart rate variability (HRV) measurement.
First Author and Year of














Park et al., 2002 [2] Software developedby the authors.
Modified spatial velocity algorithm to detect
QRS peaks. The signals were passed
through a band pass filter of 0.1–150 Hz to
eliminate unwanted noise signals.




LF: 0.05–0.15 Hz (ms2,
nu)












Yang et al., 2002 [3]
Software developed
by one of the
authors
For the RR interval rejection procedure, a
temporary mean and the standard deviation
of all RR intervals were first calculated as the
standard reference. Each RR interval was
then validated with respect to this reference.
If the standard score of an RR value
exceeded 3, it was considered erroneous or
non-stationary and was thus rejected.
The valid RR values were then resampled
and interpolated at the rate of 7.11 Hz to






LF: 0.04–0.15 Hz (nu)











Ferreira et al., 2011 [7] Not reported
Data were processed and analyzed using a
250 Hz sampling frequency (GE MARS 7.1




period of at least 18
h of the analyzable
signal were
analyzed.
Not mentioned SDNN (ms)pNN50 (%)
VLF: 0.003–0.04 Hz (ms2)
LF: 0.04–0.15 Hz (ms2)
HF: 0.15–0.40 Hz (ms2)
TP (ms2)
LF/HF
Not reported Did not performnonlinear analysis.
Zamunér et al., 2011 [5] Nerve–Expresssystem software Not reported 5 min
Data distribution









LF: 0.04–0.15 Hz (nu)
















RR intervals were visually inspected and
then filtered with the HRV software to












Not applicable Did not performnonlinear analysis.
Israeli-Mendlovic et al.,
2014 [9] Not reported
Beat intervals were visually inspected and
then filtered with the HRV software to
eliminate undesirable noise.
Not reported Not mentioned SDNN (ms)RMSSD (ms)
LF: 0.04–0.15 Hz (nu)
HF: 0.15–0.40 Hz (nu)
LF/HF
Not reported Did not performnonlinear analysis.
Amichai et al., 2017 [11] Not reported
The interbeat intervals were visually
inspected and filtered with the HRV
software to eliminate noise.
Not reported Not mentioned SDNN [ms]RMSSD (ms) LF/HF Not reported
SD1 (ms)
SD2 (ms)












Not applicable Did not performnonlinear analysis.
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Table 2. Cont.
First Author and Year of


















Abnormal beats, significant pauses, and
areas of artifact were automatically rejected
by using a computerized algorithm.
5 min Not mentioned SDNN [ms]RMSSD (ms)
LF: 0.04–0.15 Hz (ms2,
nu)




Fast Fourier transform ApEn
Amichai et al., 2019 [12] Not reported
The interbeat intervals were visually
inspected and then filtered using the HRV









LF: 0.04–0.15 Hz (ms2)
HF: 0.15–0.40 Hz (ms2)
LF/HF
Fast Fourier transform Did not performnonlinear analysis.
Katz-Leurer et al., 2019




LF/HF Not reported Did not performnonlinear analysis.
Landis et al., 2019 [54] Not reported
The aim of this study was to generate a
method for calculating HRV from ECG
waveforms. Preliminary R peak detection
and peak correction described with details.










Fast Fourier transform Did not performnonlinear analysis.
VLF—very low frequency; LF—low frequency; HF—high frequency; TP—total power; nu—normalized units; mRR—mean RR interval; avNN—average NN interval; NN—intervals
between normal R-peaks; SDNN—standard deviation of NN intervals; RMSSD—root mean square successive difference; pNN50—percentage of adjacent NN intervals that differ from each
other by more than 50 ms; SD1—standard deviation of the distance of each point from the y = x axis, specifies the ellipse’s width; SD2—standard deviation of each point from the y = x +
average RR interval, specifies the ellipse’s length; ApEn—approximate entropy; HRV—heart rate variability; QRS peak—represents flow of electrical impulse through the septum and outer
ventricles; * and ** from Landis et al., 2019: * (RR)—where R is a point associated with a peak of the QRS complex of the ECG wave and RR is the interval between successive R points; **
(ECG)—Electrocardiogram—which contains the QRS complex.
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Table 3. Main results and conclusions from included studies.
First Author and Year of
Publication Main Results and Conclusion Related to HRV
Park et al., 2002 [2]
Main results
(1) LF/HF ratio was higher in children with CP than in controls.
(2) During a head-up tilt, HR, LF, LFnu, and LF/HF increased in the controls, but not in the participants with CP.
Conclusions
Vagal withdrawal and sympathetic activation, which occur during a head-up tilt position, are not sufficient to overcome the orthostatic stress arising in children with spastic CP.
Yang et al., 2002 [3]
Main results
(1) No significant differences were observed between the controls and the children with CP.
(2) During a head-up tilt, the controls featured increased LF and LF/HF ratio and decreased HF. The children with CP did not present any differences between the supine position and a head-up tilt.
Conclusions
The disturbed balance of activity between the sympathetic and parasympathetic nervous system observed in the study might result from the loss of hemispheric influence in patients with CP; however, further
investigation is clearly necessary.
Ferreira et al., 2011 [7]
Main results
The group of children with CP presented higher HF and LF values and lower LF/HF compared to the controls.
Conclusions
Individuals with CP present an increased cardiovascular risk, a disturbed sympathovagal balance that could contribute to the salivary secretion alterations observed.
Zamunér et al., 2011 [5]
Main results
(1) The control group presented a higher HFnu value and a lower LFnu value compared to the children with CP in the supine position.
(2) During standing, the controls featured increased LFnu and decreased HFnu. The children with CP did not present any differences between the supine position and standing.
(3) There was a significant correlation between the GMFCS class and the LFnu index, the HFnu index, and the LF/HF ratio.
Conclusions
Children with CP present lower HRV indices, indicating sympathovagal imbalance. The decrease of HRV in children with CP is related to the motor impairment level.
Kholod et al., 2013 [8]
Main results
(1) The children with CP presented higher mean HR and lower time domain values at rest in comparison to the controls.
(2) There was no association between HR and HRV and motor performance (GMFM score) in the children with CP.
(3) The children with CP at different disability levels showed similar HRV values.
Conclusions
Among children with CP, the cardiac autonomic mechanism is less efficient at rest and less adaptive to exercise and activity as compared to typically developed children.
Israeli-Mendlovic et al., 2014 [9]
Main results
(1) The children with GMFCS IV presented increased HR and reduced HRV during the GMFM assessment, the repeated task, and during passive standing. No such effect was noted among the children with
GMFCS V.
(2) No significant differences were noted in the HR or HRV parameters based on activity level.
Conclusions
HR autonomic regulation system has an opportunity to be influenced by training in children with CP GMFCS IV.
Amichai et al., 2017 [11]
Main results
(1) HR increased during the last stage of the treadmill test compared with the rest. The RMSSD was reduced during the last two minutes of the treadmill test compared with the rest.
(2) The HR and RMSSD mean value at the second minute post-test were not significantly different from the pre-treadmill rest value.
Conclusions
Further studies are needed to assess the possible influence of exercise protocols on the cardiac autonomic system.
J. Clin. Med. 2020, 9, 1141 12 of 25
Table 3. Cont.
First Author and Year of
Publication Main Results and Conclusion Related to HRV
Cohen-Holzer et al., 2017 [13]
Main results
Significant reduction in HR and an increase in RMSSD 3 months post-intervention.Conclusions
An intensive hybrid program (10 days, 6 h per day) effectively improved the cardiac autonomic regulation system.
Kim et al., 2017 [56]
Main results
(1) There were significant differences between the patients with CP and acute brain injury in the mean HR, RMSSD, and all indices of the frequency domain analysis.
(2) The mean HR, normalized LF, and the LF/HF ratio decreased in the group of children with CP.
Conclusions
Patients with acute brain injury have higher sympathetic excitatory activity and more dominant sympathetic power than the parasympathetic power compared to the control group. Presence of paroxysmal
sympathetic hyperactivity symptoms were noted among the children with acute brain injury compared to the age- and sex-matched control group of children with CP.
Amichai et al., 2019 [12]
Main results
(1) Children with CP have lower spirometry and HRV values at rest compared to TD children.
(1) The mean reduction of the breathing rate during paced breathing among the children with CP was significantly smaller.
Conclusions
Children with CP have the ability to perform paced breathing training in order to influence their respiratory rate. HRV parameters increase during a paced breathing practice in children with CP, showing an
impact on the cardiac autonomic control system.
Katz-Leurer et al., 2019 [14]
Main results
(1) There were significant differences in all HRV measures between groups, with significantly lower mRR, SDNN, and RMSSD values, and higher LF/HF values in the children with CP versus the controls.
(2) Significant differences between the patients with five different GMFCS levels were noted in all HRV measures.
Conclusions
Assessing appropriate protocols for improving autonomic regulation in children with CP is the next step needed.
Landis et al., 2019 [54]
Main results
The authors presented an active video game data collection protocol and a methodology to calculate HRV from the ECG data obtained via an HR monitor.
Conclusions
The proposed methodology allows to extract RR intervals and HRV measures from ECG waveforms during gaming physical activities in youths with CP. The method is currently tailored towards active video
game sessions in a specific game, but could easily be adapted to other protocols and ECG devices for future experiments.
CP—cerebral palsy; TD—typically developed; GMFCS—Gross Motor Function Classification System; GMFM—Gross Motor Function Measure; HR—heart rate; HRV—heart rate
variability; LF—low frequency; HF—high frequency; nu—normalized units; mRR—mean RR interval; SDNN—standard deviation of NN intervals; RMSSD—root mean square successive
difference; ECG—electrocardiography.
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4. Discussion
The present study had two parallel aims: to review the existing findings of HRV in pediatric
patients with CP and to verify the compliance of these studies with the current guidelines for
measurement, physiological interpretation, and clinical use of HRV.
Our main results revealed that children with CP present significantly higher resting HR and lower
HRV and lower cardiac autonomic system adaptation to exercise and activity compared to typically
developed children, but also decreased values of selected HRV parameters in those dependent on
adult assistance for mobility compared to those who are generally independent. Physical exercises
improve cardiac autonomic regulation in pediatric patients with CP by reducing HR and breathing
rate and increasing values of selected HRV parameters. However, most of the studies reviewed did
not follow the current guidelines on RR recording and HRV analysis or provided limited information
concerning methodological aspects, thus limiting their reliability and replication.
HRV analysis provides an insight into the autonomic modulations of cardiac periodicity and
consequently can be used to examine autonomic responsiveness [46]. However, after more than
30 years from the first studies on HRV, there is still resistance to using HRV as a tool for medical
decision-making in the clinical practice. One of the reasons for this observation is the limitations/pitfalls
of HRV analysis, which may lead non-experts in the field to misinterpret its results. Clarification
of the limitations, drawbacks, and strengths of HRV is required to contribute to overcoming these
methodological difficulties in future studies.
4.1. HRV Changes in Children with CP
Patients with CP have an increased risk of death, mainly due to the circulatory and respiratory
systems diseases [59,60]. Therefore, it is important to examine cardiac, cardiorespiratory, and cardiac
autonomic function in patients with CP to better understand the disease and to establish new therapeutic
goals for this condition.
Many neurological disorders associated with brain damage, e.g., Parkinsonian syndrome, multiple
sclerosis, and Guillain-Barré syndrome, are associated with decreased HRV values [61]. The results
and conclusions of the studies included in this review also highlighted that patients with CP are
characterized by impaired cardiac ANS (see Table 3). In 2014, Amichai and Katz-Leurer published a
review based on the articles published between 1990 and 2013 assessing the function of the autonomic
cardiac regulation among children with CP [10]. However, since that period, eight new articles in
this area have been published [8,9,11–14,54,56]. Amichai and Katz-Leurer concluded that there is a
trend that children with CP suffer from impaired cardiac autonomic system regulation [10]. In the
supine position, patients with CP presented significantly higher resting HR and reduced HRV, but
also different responses to stimuli, such as selected movement maneuvers (posture change, head-up
tilt, or standing), compared to typically developed children. Results of the articles published between
2013 and 2019 confirmed this trend, but also provided new findings (see Table 3). Authors of these
studies suggested that children with CP present lower cardiac autonomic system adaptation to exercise
and activity [8] and lower spirometry [12] compared to typically developed children; non-optimal
HR reduction after a submaximal treadmill test indicating low reactivation of the parasympathetic
system [11]; decreased values of selected time-domain HRV parameters in those dependent on adult
assistance for mobility compared to those who are generally independent [14]. Israeli-Mendlovic
et al. [9] suggested and Cohen-Holzer et al. [13] and Amichai et al. [12] showed that some forms of
physical exercises and training improve cardiac autonomic regulation in pediatric patients with CP by
reducing HR and breathing rate and increasing values of selected HRV parameters.
Impaired cardiac autonomic function in children with CP might be due to the damage of the
developing brain or to the sedentary lifestyle, or both synergistically interacting [10,12]. Recently,
the association between the anterior cingulate cortex (ACC), a bilateral cortical structure in the
medial wall of the brain [62], and HRV has been shown [63,64]. Authors reported that increases
in HRV were accompanied by increases in functional connectivity between amygdala and dorsal
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ACC [65], the existence of positive associations between ACC cortical thickness and differences in
vagally-mediated HRV [63] and between cerebral blood flow in the ACC and the high frequency
component of HRV [64]. Importantly, it was shown that in children with CP, structural connectivity to
the ACC was reduced [62,66].
In apparently healthy children, longer time spent in the sedentary lifestyle, lower physical activity
and cardiorespiratory fitness levels were associated with poorer cardiac ANS function [67]. Many
children with CP presented lower physical activity and cardiorespiratory fitness levels than their
typically developed peers [68,69]. Moreover, in children with CP, sedentary lifestyle begins very early,
i.e., in the childhood years [70]. Thus, the impaired autonomic modulation of cardiac oscillations in
children with CP may be related to both the alterations attributed to disturbances occurring in the
specified areas of developing brain, and prolonged sedentary behaviors.
4.2. Compliance of the Studies to Recommendations and Guidelines
Quintana and Heathers suggested that uncontrolled variables within experimental environments
may significantly influence HRV results [34]. Careful consideration of such crucial contextual,
environmental, physiological, and methodological factors is required to build more precise research
protocols and ensure researchers obtain more accurate and reproducible results. Examples of
such factors are the time of the day to record the data (in the case of short-time recordings);
subject-characteristic variables such as age, sex, HR, breathing rate, health and physical activity
status, control for medication, food and water consumption, voiding of the bladder; position of the
body during short-time recordings; the quality of recorded signals (recording period length, detection
or recording method, sampling frequency, breathing pacing—paced or free breathing); as well as
the tools used to analyze HRV values (i.e., how HRV metrics were calculated—software, removal of
artifacts, frequency band cutoffs, power spectral analysis method, etc.) [33,34,37,40,61,71].
4.2.1. Study Sample
The studies that met the inclusion criteria involved 397 pediatric participants with CP (number
of children with CP in experimental groups ranged from 10 to 110 participants). In seven studies,
results for the control group (mostly typically developed children) were also presented. The number of
typically developed children was the same or smaller compared to the experimental group, i.e., from
12 to 35 participants. It should be emphasized that in many studies, participants with CP were divided
into sub-groups according to the GMFCS, which decreased the total number of participants in selected
groups [8,9,14].
The distribution analysis of 297 HRV effect sizes from between-group/case-control studies
performed by Quintana [72] highlighted that the Cohen’s guidelines [73] may underestimate the
magnitude of small and large effect sizes. Therefore, it is suggested that HRV studies were generally
underpowered. In case-control HRV studies, for vagally-mediated HRV measures, in order to achieve
80% of statistical power, samples of 233, 61, and 21 participants are required to detect small (effect size
of 0.25), medium (effect size of 0.5), and large (effect size of 0.9) effect sizes, respectively (significance
criterion of alpha = 0.05) [40,72]. Based on this statistical consideration, large effect size is observed
in all the studies included in this review. Future investigations should include a larger pediatric
population of patients with CP to confirm previous results based on smaller samples.
4.2.2. Data Acquisition and Processing
• Device, software, duration of recordings, and sampling frequency
Authors of eight studies analyzed in this review specified the name of the software that was used
to record the raw signals and obtain the RR intervals: in two articles, the electrocardiography was
collected by authors using an electrocardiogram (ECG) device; whilst in seven studies, a heart rate
monitor was used; in the other three articles, there was no information about the name of the device and
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the software used or the authors stated that they used their own software. In HRV studies, details on
the raw signal acquisition device and the software used for RR interval generation and analysis should
be provided. If the information on the acquisition device or the software used to calculate HRV is not
available, a more precise methodological specification should be ensured to allow reproducibility [35].
RR interval data are generated via ECG (more traditionally) or, more recently, by
photoplethysmography (PPG) [35,39]. Although ECG and PPG presented discrepancies of about 6%
for most HRV measurements [74], selected PPG devices showed satisfactory agreement with ECG
in some, but not all populations [75–77]. In terms of identification and correction of artifacts and
ectopic beats, and also of the correct identification of cardiac events, e.g., cardiac dysrhythmia, ECG is
more accurate than PPG [35,40]. The use of traditional ECG to obtain RR intervals in patients with
CP in, e.g., a pre-post intervention study with stable conditions is relatively feasible. However, since
ECG recording during rehabilitation/exercise activities in this population may be problematic, heart
rate monitors could be used more freely during such activities. It was recently confirmed that in a
healthy population, popular heart rate monitors are valid methods to detect RR intervals [78] and to
record HRV [79]. In future studies, it should be verified whether heart rate monitors can produce ECG
comparable to conventional devices, and reliable RR intervals (and, consequently, HRV measurements,
for details see [80]) in children with CP in different conditions.
The information about the duration of recordings and the RR series length used to calculate HRV
parameters should be provided separately and distinctly, because they do not represent the same
information. Twenty-four-hour ECG recording was performed in one study included in this review.
The author of the study clearly stated that the NN intervals over a period of at least 18 h were analyzed.
The duration of recordings in the other 11 studies ranged between 3 and 15 min. In one study, the
period of time of the RR interval series and the period of time used to calculate HRV parameters was
the same (288 s); in other studies, where short-term recordings were analyzed, the 5 min time interval
was used to calculate HRV parameters. However, none of the analyzed studies reported the number of
points of RR series. Since the number of points of RR series is a function not only of time, but also of
HR, and considering that robustness of some HRV analysis methods depends on the RR series length
(such as nonlinear approaches), this information should be reported.
Sampling frequency was provided only in four of the 12 analyzed studies (from 250 to 1000 Hz).
Sampling frequency is an important issue, and even if HR monitoring systems are used, it should be
provided, since it has a direct effect on the resolution of RR intervals, thus limiting assessment of the
actual HRV. Lower signal sampling rate (i.e., < 250 Hz) decreases the validity of HRV parameters,
mostly of frequency-domain and nonlinear indices [25,37,39,40,81]. It has been suggested that sampling
rates lower than 250 Hz, but not lower than 100 Hz, may be acceptable if appropriate interpolation
algorithms are used [39]. The sampling rate between 250 and 500 Hz was recommended by the Task
Force experts; however, other researchers suggest a sampling rate between 500 and 1000 Hz [40].
• Recording conditions: time of the day, room (lights/voices/temperature), activities before recordings
(sleep routine, physical activities, meals, drinks, using the toilet), and heart rate stabilization
A number of environmental/external factors should be controlled in HRV experiments. It has been
extensively addressed by some authors, e.g., by Quintana and Heathers (2014) [34], Heathers (2014) [33],
Fatisson et al. (2016) [61], and Laborde et al., (2017) [40]. Seven of the analyzed studies in this review
provided limited information on the conditions during signal acquisition, mostly concerning short-term
recordings, as it is difficult to ensure all details on 24-h recordings. There was no study (in case of
short-term recordings) with a full description of the time of the day when recording was performed,
conditions concerning the room where the study took place and participant activities before recordings.
Those conditions should be provided and, if possible, standardized for all participants. Laborde et al.,
(2017) [40] provided a useful demographic questionnaire that helps to collect and control most of the
confounding variables influencing HRV ([40] Supplementary Materials (Data Sheet 1)).
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Only in four studies was the exact time planned for rest/HR stabilization before starting data
recording provided, and it ranged from 5 to 30 min. HR is generally unstable and changes over
time and after postural changes [34,82]. Therefore, a minimal steady HR signal is required for the
analysis of short-term HRV and it is usually obtained by an appropriate time allowed for volunteers to
acclimatize to the recording environment process. This process usually consists of a resting period
of 5–10 min before the experiment begins [35,39,40]. However, some authors suggested that in some
populations, even shorter acclimatization time periods may be implemented [83]. During baseline
recordings, participants should be instructed to remain still without speaking [40]. Not speaking
during the recording is particularly important, because it eliminates the respiratory component of HRV
(respiratory sinus arrhythmia). Only in one study the children were asked not to talk or to move during
data registration. In three studies, participants were instructed how to breathe during data collection.
• Respiratory rate during recordings and breathing control
HRV (mostly frequency-domain parameters) is affected by respiratory depth and frequency [34,
84,85]. The low and high frequency bands (LF and HF, respectively) of HRV are affected by breathing
when the patient breathes in a rate of ~3 to 9 and 9 to 24 breaths per minute, respectively [37,40,43].
The frequency band for HF was standardized to 0.15–0.40 Hz; however, for pediatric subjects, who
breathe faster than adults [86], the range should be appropriately adjusted [35,37,40]. As the spectral
powers at LF and HF bands are commonly attributed to sympathetic and vagal influences on the HR,
the investigator should be aware that changes in the respiratory frequency may led to the invalidation
of spectral indices. For instance, when any subject breathes very slowly, in the range of the LF band
(~3 to 9 breaths per minute), the classical interpretation of the HF band as the vagal influence on the
HR is flawed.
Breathing rate was measured in three studies concerning HRV in children with CP. The children
were instructed to breathe with a metronome at 15 breaths/min [2] or maintained spontaneous breathing,
presenting 10 to 20 breaths per minute [5]. In a recent study, Amichai et al. assessed the impact of
the breathing rate on the cardiac autonomic dynamics in children with CP and in typically developed
children [12]. The pacing procedure assumed slow and deep inhalation through the nose to a count
of four, followed by a slow and complete exhalation to a count of six. The procedure was supported
by watching the breathing waves on the screen and attempting to draw prolonged waves in each
breathing cycle [12]. In both conditions, i.e., during rest and paced breathing, there were no significant
differences in the respiratory rate between children with CP and typically developed children [12].
A significant reduction in the breathing rate during paced breathing noted within each group was
accompanied by a nominal decrease in HR and a significant increase in the standard deviation of NN
intervals (SDNN) and the root mean square of successive difference intervals (RMSSD) [12].
It is important to question whether changes in HRV parameters were associated primarily with
changes in respiratory rate or changes in HR [87]. Even though HRV alterations resulting from changes
of the respiration pattern are expected, knowing the respiratory rate is needed to establish whether the
changes in HRV values are primarily due to changes in respiratory frequency or not [40], especially in
populations that present different breathing frequencies or when an experimental task modifies the
respiratory pattern [34,35].
It still remains that there is no optimal solution on how to record and control respiratory rate in
HRV studies [34]. Quintana and Heathers proposed to measure the subject’s natural/normal respiration
rate, and use the obtained frequency for respiratory pacing in the resting state registration [34]. Another
solution, especially helpful in populations composed of children, is to perform acclimatization to the
recording environment, which is intended to stabilize the respiration rate. This procedure consists
of placing the individual in the position of the recording for a minimum period of time in order to
stabilize both HR and respiration. Then, the respiratory rate can be derived from the ECG using
proper algorithms [88] or be simultaneously recorded with the ECG using a respiratory belt. In another
scenario, where an HR monitor is used to record RR intervals, authors may monitor respiratory rate
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using a camera (e.g., [89]). Subsequently, exclusion of participants with a respiratory rate out of
the range established by the statistical analysis or changing the HRV frequency bands is warranted.
Importantly, the choice of spontaneous or paced breathing during the recordings will have different
consequences for HRV analysis and should be taken into account by researchers [90–94].
4.2.3. HRV Analysis
• Software, artifact correction, time series length (time/beats), information about data normality
Only one of the twelve studies included in the presented review provided all the details on the
software used to calculate HRV parameters, the artifact correction method, and the time series length
used to calculate HRV indices. As mentioned above, details on how HRV parameters were calculated,
as well as the software used for RR interval analysis should be routinely provided. We propose that a
detailed description of the methods should be presented even when the software used in the analysis
is reported.
Artifacts may significantly influence values of HRV parameters [27,37,95,96]. Before HRV
parameters can be calculated, preprocessing of the raw data is necessary and should also be described.
Data reduction/replication and cleaning procedure should be explained and justified. All abnormal
beats (i.e., not generated by sinus node depolarization) and artifacts (e.g., missed or spurious beats)
should be identified and properly processed [27,33,35,39,45,97,98].
The length of the RR intervals or the HR series is methodologically relevant, especially in the
protocols that are dependent on the number of samples [39]. Different groups of authors have proposed
various durations needed to obtain reliable time- and frequency-domain parameters [37,39], as well as
nonlinear approaches [99–101]. However, it is commonly recommended, according to the Task Force
paper [25], to calculate linear HRV short-term parameters from a 5 min time interval to ensure adequate
comparison between studies [40]. For nonlinear methods, the choice of the series length depends
on the method under consideration. A reasonable general approach is to follow the corresponding
original paper recommendations to allow comparisons between studies.
Another point to be considered regards the statistical analysis. Out of the articles included
in the present review, only three stated that data distribution was checked. In many HRV studies,
most parameters presented a non-normal distribution. When this is the case, to meet statistical
requirements, non-parametric tests should be used, or a log transformation procedure be performed,
and log transformed data should be presented and evaluated [40,102].
• Frequency domain and nonlinear HRV parameters
Two frequency domain parameters are widely used in HRV studies, i.e., LF and HF powers
(and, consequently, the LF/HF ratio), with commonly used bands 0.04–0.15 Hz and 0.15–0.40 Hz,
respectively [25,39,45]. Such bands were used in all (with one exception, and one study where the
authors did not specify frequency bands) the studies concerning HRV in children and adolescents with
CP included in the presented review. However, for the pediatric participants who breathe faster than
24 breaths per minute, the range for HF should be adequately set by increasing the upper limit of the
HF band [35,37,40]. Quintana et al. recommended for these population to set the HF band width at
0.24–1.04 Hz at rest [35].
Fast Fourier transform and autoregressive spectral analysis are the most commonly used methods
for frequency-domain HRV analysis [45]. However, results obtained by these analyses could not be
considered interchangeable and compared to each other, at least in healthy subjects at rest [103]. A full
description of which frequency-domain method was used with additional methodological assumptions,
such as the windowing method, window length, and overlap, should be given [35]. Authors of five
studies specified the frequency analysis method used to obtain frequency-domain parameters and
only one author provided more details on sampling and windowing.
Frequency-domain HRV parameters can be expressed in absolute (ms2) or relative, normalized
(nu), units [25,37]. It is recommended to present values in both units [40], as there are some limitations
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when using only one of them [33]. In general, the absolute power of the HF band can be considered a
robust index of cardiac vagal modulation, but the absolute power of the LF band is not a pure index
of cardiac sympathetic modulation. Some authors showed, using autonomic maneuvers, that the
normalized power in the LF band represents a more robust index of cardiac sympathetic control [104].
In two studies, authors presented data in both units; in two studies, powers were presented only in
absolute units; and in three, only in normalized units.
Only two studies presented results obtained by using methods of nonlinear
dynamics—approximate entropy and SD1 and SD2 from the Poincaré plot analysis. An important
constraint of time and frequency methods commonly used for HRV analysis is the assumption of
linearity in the system under analysis. For example, the spectral analysis assumes that HRV signals
are the result of a linear combination of periodic components where certain frequencies are related to
the activity of the autonomic sympathetic or parasympathetic nervous system. Consequently, these
frequency components are considered all independent of each other, i.e., there are no interactions
between the autonomic components. However, it is known that cardiovascular control involves
nonlinear interactions between physiological systems, with complex dynamics. Therefore, nonlinear
methods appear as complementary and important tools to extract information from HRV series, and
we strongly recommend their use in studies of HRV [105,106]. Recently, Sassi et al., (2015), on behalf
of the European Heart Rhythm Association, reviewed some of the most used nonlinear approaches
and their contributions to HRV understanding [107]. However, it is recognized that no single method
(linear or nonlinear) is capable of extracting the full complexity of physiological systems by itself,
pointing to the importance of combining multiple HRV parameters to characterize physiological and
physiopathological conditions [108].
4.2.4. HRV Correction for HR
The majority of HRV studies, including those on patients with CP reviewed here, have not
accounted for the significant correlation between HRV parameters and mean HR. In light of our current
knowledge, HRV is primarily HR-dependent in adults [28–31] and children [109,110], i.e., different HR
may exert different impact on HRV and, to some extent, may determine HRV values [32,36,111–117].
Correction methods were proposed and it was highlighted that the HRV dependence on HR should be
removed before drawing conclusions on HRV changes [118]. However, recently, such an approach was
discussed, but the authors recommended that any relationships between the prevailing heart period
and the HRV parameters should always be formally examined and reported [44]. Researchers and
clinicians should also be aware that not all HRV indices are dependent on mean HR [119].
4.3. Lack of Methodological Information in Existing Studies on HRV in Pediatric Participants with CP
Controlling all the possible confounding factors and reporting all the methodological aspects
in the study is crucial for results interpretation, reproducibility, and translating the findings into the
clinical practice. The methodological heterogeneity observed in the reviewed studies and the lack
of information provided may account for some controversial results and limit the insights and the
comparisons between different studies. Furthermore, it directly impacts health professionals dealing
with this population due to uncertainty on how to use these findings in clinical settings. Although
HRV provides important clinical markers, it remains underutilized and raises several issues about its
clinical applicability [120]. Thus, following the methodological guidelines for RR recording and HRV
analysis and properly reporting them is required to increase HRV clinical use by health professionals.
5. Conclusions
In summary, pediatric patients with CP presented significantly higher resting HR and a reduced
HRV, as well as different responses (or no effect) to selected movement maneuvers compared to typically
developed children and decreased values of selected HRV parameters in those dependent on adult
assistance for mobility compared to those who are generally independent. Physical exercises positively
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influence cardiac autonomic regulation by reducing HR and breathing rate and increasing values
of selected HRV parameters. However, most HRV studies in this population failed to provide the
necessary details concerning data acquisition and HRV measurements, so the experimental design could
not be replicated in laboratories or clinical settings. Thus, the lack of details concerning methodological
aspects of these studies significantly limits their replication and confidence in interpretation [35].
It is important that authors of future studies on HRV in patients with CP are aware about recent
controversies of HRV measurement and follow the recently developed HRV metrics, as well as their
physiological interpretation and meaning [121–127]. Following the current guidelines will help to
identify and eliminate most methodological limitations and misinterpretations.
Dan (2017) emphasized that data from studies on the ANS in patients with CP “are necessary
to discuss possible implications for clinical practice in terms of diagnosis, outcome” [128] (p. 1).
Developing a better understanding of ANS activity in patients with CP is required to better understand
cardiovascular diseases in this group of patients. Moreover, studies highlight the importance of
non-autonomic influences in HRV [129–131], which are also a potential source of important information
to understand the impairments in patients with CP and should be taken into account in future studies.
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